Purchase Order 75N93024P00527
Award Date 4/8/24
Potential Completion Date 6/7/24
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Psomagen Inc. has been awarded a purchase order from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases for library preparation, sequencing, and basic analysis services. The firm fixed price contract has a potential value of $14,000 and runs through April 13, 2024 with performance taking place in Bethesda, Maryland. Psomagen will leverage its CLIA certified and CAP accredited facilities to deliver genomic sequencing...
- The National Institute of Allergy and Infectious Diseases awarded a $17,810 firm fixed price purchase order to Psomagen Inc. on September 13, 2021, with an ultimate completion date of August 4, 2022. This contract action was undertaken to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. The work was performed in...
- This is a $206,250 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is for total RNA sequencing services, with an option to increase the value. The awardee is Psomagen Inc., a for-profit manufacturer of genomics and molecular biology services based in Rockville, Maryland. This contract does not have a set-aside designation. Psomagen is...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
- The U.S. government awarded a $9,220 firm fixed-price purchase order to Psomagen Inc. for DNA library preparation and sequencing services, including additional quality control for replacement samples. The contract was set aside for small businesses and awarded on February 13, 2019, with an ultimate completion date of June 21, 2019. Work is being performed in Potomac, Maryland, and the funding agency is identified as the Northeast Area civilian federal agency component. Psomagen Inc., a...
- This federal contract award, valued at $44,940.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a for-profit manufacturer of genomic sequencing and bioinformatics services. The contract is for "SEQUENCING NOVASEQX 25B 150PE, FLOW CELL" and has a firm fixed-price structure with a completion date of November 16, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and has...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $9,460 firm fixed-price purchase order to Psomagen Inc. for COVID-19 RNA isolation, DNA generation, and library preparation services under the FY26 Unlisted Data Objective (UDO) Initiative. The contract, awarded on September 20, 2022, with an ultimate completion date of September 18, 2023, was performed at Psomagen's facility in Rockville, Maryland. No set-aside designation was applied to this procurement. Psomagen, a...
- This firm-fixed price purchase order for $600,000 was awarded by the National Institute on Aging, a component of the National Institutes of Health within the Department of Health and Human Services, to Psomagen, Inc. for whole genome sequencing services. Under the terms of the contract, Psomagen will sequence 1,000 human samples to 30x coverage using Illumina sequencing technologies and deliver raw sequencing data files within 4-6 weeks. The work will be performed in Potomac, Maryland over a one...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $11,381 firm-fixed-price purchase order contract was awarded on July 5, 2011, with a completion date of July 4, 2012. The contract did not have a set-aside designation. Psomagen Inc. is a multiomics contract laboratory that provides a range of genomic and molecular biology services,...